[1]王小兵,黄世铭,廖静怡,等.氢氯噻嗪药物共晶的制备、表征及量化计算[J].江西师范大学学报(自然科学版),2015,(03):240-245.
 WANG Xiaobing,HUANG Shiming,LIAO Jingyi,et al.The Synthesis,Characterization and Quantum Calculations of Cocrystals Based on Hydrochlorothiazide[J].,2015,(03):240-245.
点击复制

氢氯噻嗪药物共晶的制备、表征及量化计算()
分享到:

《江西师范大学学报》(自然科学版)[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2015年03期
页码:
240-245
栏目:
出版日期:
2015-05-31

文章信息/Info

Title:
The Synthesis,Characterization and Quantum Calculations of Cocrystals Based on Hydrochlorothiazide
作者:
王小兵;黄世铭;廖静怡;徐永群;唐斯萍;卢文贯
1.韶关学院化学系,广东 韶关 512005; 2.衡阳师范学院化学与材料科学系,湖南 衡阳 421008
Author(s):
WANG XiaobingHUANG ShimingLIAO JingyiXU YongqunTANG SipingLU Wenguan
关键词:
氢氯噻嗪 药物共晶 制备 表征 量化计算
Keywords:
hydrochlorothiazide pharmaceutical cocrystals synthesis characterization quantum calculations
分类号:
O 641.3
文献标志码:
A
摘要:
以氢氯噻嗪(HCT)作为药物活性成分(API),以烟酰胺、烟酸作为共晶形成物(CCF),在室温条件下制得2种药物共晶HCT·NCA(1)、HCT·NNA(2).通过X-射线单晶衍射测定了它们的晶体结构,并进行了元素分析、红外光谱、X-射线粉末衍射表征.此外,利用Gausian 03W程序,在B3LYP/6-31G(d)水平上对2种化合物进行了结构全优化,对其分子轨道能量、前线分子轨道、自然键轨道(NBO)等进行了量子化学计算分析.
Abstract:
With hydrochlorothiazide as the active pharmaceutical ingredient(API),nicotinamide and nicotinic acid as the cocrystal former(CCF),two pharmaceutical cocrystals HCT·NCA(1),HCT·NNA(2)were successfully synthesized at room temperature,respectively.The crystal structures were determined by single-crystal X-ray diffraction,and they were further characterized by elemental analysis,infrared spectroscopy and powder X-ray diffraction.In addition,based on the B3LYP/6-31G(d)level with Gaussian 03W program,the full geometry optimization,the orbital energies,the frontier molecular orbital and the natural bond orbital of the two compounds have been investigated.

参考文献/References:

[1] Childs S L,Stahly G P,Park A,et al.The salt-cocrystal continuum:the tnfluence of crystal structure on ionization state [J].Mol Pharmaceutics,2007,4(3):323-338.
[2] Fleischman S G,Kuduva S S,McMahon J A,et al.Crystal engineering of the composition of pharmaceutical phases:multiple-component crystalline solids involving carbamazepine [J].Cryst Growth Des,2003,3(6):909-919.
[3] 陈嘉媚,吴传斌,鲁统部.超分子化学在药物共晶中的应用 [J].高等学校化学学报,2011,32(9):1996-2009.
[4] 高缘,祖卉,张建军.药物共晶研究进展 [J].化学进展,2010,22(5):829-836.
[5] Clarke H D,Arora K K,Bass H,et al.Structure-stability relationships in cocrystal hydrates:does the promiscuity of water make crystalline hydrates the nemesis of crystal engineering? [J].Cryst Growth Des,2010,10(5):2152-2167.
[6] McNamara D P,Childs S L,Giordano J,et al.Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API [J].Pharm Res,2006,23(8):1888-1897.
[7] Zhang Tingting,Wang Haitao,Jia Jiangtao,et al.Syntheses and pharmacokinetics properties of an iloperidone pharmaceutical cocrystal [J].Inorg Chem Commun,2014,39:144-146.
[8] Takaaki M,Yasuo Y,Etsuo Y,et al.Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir [J].International Journal of Pharmaceutics,2012,422:160-169.
[9] Irena T,Shyam K,Jag S,et al.Pharmaceutical characterisation and evaluation of cocrystals:Importance of in vitro dissolution conditions and type of coformer [J].International Journal of Pharmaceutics,2013,453:380-388.
[10] Yan Yan,Chen Jiamei,Geng Na,et al.Improving the solubility of agomelatine via cocrystals [J].Cryst Growth Des,2012,12(5):2226-2233.
[11] Karki S,Fricic T,Fábián L,et al.Improving mechanical properties of crystalline solids by cocrystal formation:new compressible forms of paracetamol [J].Advanced Materials,2009,21:3905-3909.
[12] 陈新谦,金有豫,汤光.新编药物学 [M].15版.北京:人民卫生出版社,2003:90-491.
[13] 尚校军,张疆莉,马素.氢氯噻嗪固体分散体的制备及其溶出溶解性 [J].中国医院药学杂志,2010,30(15):1293-1295.
[14] 王玮,钱佩佩,曹凯,等.氢氯噻嗪包合物的拉曼光谱和红外光谱研究 [J].药物分析杂志,2012,32(2):370-372.
[15] Dreizler R M,Gross E K U.Density functional theory [M].Heidelberg,Germany:Springer-Verlag,1990.
[16] Lee C T,Yang Weitao,Parr R G.Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density [J].Phys Rev B,1988,37(2):785-789.
[17] Palash S,Lalit R.Tuning solubility and stability of hydrochlorothiazide co-crystals [J].Acta Crystallogr B Struct Sci Cryst Eng Mater,2014,B70:81-90.
[18] 刘晓莉,张美丽.配合物[Zn(pda)(bpp)]n的合成、晶体结构与荧光性质 [J].江西师范大学学报:自然科学版,2014,38(3):304-307.
[19] Li Rongqi,Zhao Pusu,Zhu Yulan,et al.Synthesis,crystal structures and density functional theory study of dimeric copper(II)complexes of a tridentate Schiff-base ligand [J].Inorg Chim Acta,2009,362(11):4081-4086.
[20] 胡宗球,叶效昭,施少敏,等.配合物[M(AAABA)2·(py)2(H2O)2,M=Zn、Mn]的合成、晶体结构、荧光性质和理论研究 [J].无机化学学报,2009,25(8):1389-1395.
[21] Zorlu Y,Can H,Aksakal F.A novel 2D chiral silver(I)coordination polymer assembled from 5-sulfosalicylic acid and(2S,4R)-4-hydroxyproline:Synthesis,crystal structure,HOMO-LUMO and NBO analysis [J].Journal of Molecular Structure,2013,1049:368-376.
[22] Dobrzyńska D,Lis T,Woz'niak J,et al.Crystal structure,spectroscopic,magnetic and theoretical studies of[bis(hippurato)bis(benzimidazole)copper(II)] propanol 1/4hydrate [J].Polyhedron,2009,28:3150-3154.

备注/Memo

备注/Memo:
国家自然科学基金(21071099);2013年广东省大学生创新训练计划(1057613-025);广东省普通高校特色创新
更新日期/Last Update: 1900-01-01